Table 2 Comparison of myPath and FISH in Reimann et al. [1] using the clinically-validated classification system provided with the myPath test results
From: Reply to Reimann et al.
Case type | Sensitivity | Specificity |
|---|---|---|
All ambiguous cases | ||
FISH | 61% | 100% |
myPath | 67% | 96% |
‘Challenging spitzoid cases’ | ||
FISH | 60% | 100% |
myPath | 75% | 95% |
‘Challenging nevoid cases’ | ||
FISH | 63% | 100% |
myPath | 80% | 100% |
